NSG
FLGT icon

Nalls Sherbakoff Group’s Fulgent Genetics FLGT Stock Holding History

Nalls Sherbakoff Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.89K Hold
100
– – ﹤0.01% 339
2023
Q3 		$2.67K Hold
100
– – ﹤0.01% 335
2023
Q2 		$3.98K Hold
100
– – ﹤0.01% 317
2023
Q1 		$2.97K Buy
+100
New +$3.22K ﹤0.01% 350

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nalls Sherbakoff Group's FLGT Position: Q4 2023 in Review

Nalls Sherbakoff Group held its Fulgent Genetics (FLGT) position steady in Q4 2023 at 100 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

Nalls Sherbakoff Group first reported a position in FLGT in Q1 2023 and has held it in 4 quarters since. The position peaked at $3.98K in Q2 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Nalls Sherbakoff Group held 100 shares of Fulgent Genetics worth $2.89K as of Q4 2023.
  • Nalls Sherbakoff Group left its Fulgent Genetics share count unchanged in Q4 2023.
  • Fulgent Genetics made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q4 2023, its #339 holding.
  • Nalls Sherbakoff Group first reported a position in Fulgent Genetics in Q1 2023 and has held it in 4 quarters since.
  • Nalls Sherbakoff Group's Fulgent Genetics position peaked at $3.98K in Q2 2023.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2023, filed 9 Apr 2024.